FindMyKOL

Blanca Vazquez, MD

Basic profile

New York University

ORCID↗NPI↗
✓ Itemized record
RegionNew York, NY · NortheastSpecialtyNeurologyFocusNeurology
Last active 2023FindMyKOL type: NationalLatest publication2023Online presenceNot yet checkedPayments2021 onwardNIH fundingNot yet indexedWhy? →

Blanca Vazquez is a Neurology physician affiliated with New York University. OpenAlex indexes 61 publications with 3,626 citations (h-index 30).

Overview

Scholarship

indexed output and impact (OpenAlex)
View publications ↓
61publications

Publications indexed by OpenAlex, matched via ORCID. Counts exclude supporting files.

3,626citations

Citations across these publications.

30h-index

H-index from these publications.

Clinical & industry

trials, payments and federal funding
4companies · 2021 onward

Companies reporting payments to CMS. Facts, not judgments.

View payments ↓

Industry payments

4 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:

View the CMS Open Payments record ↗

Services and research payments matched to this physician's NPI in CMS Open Payments. Meals, travel and gifts are counted in the company total and not listed here. Research funding is listed under each investigator the record names.

Medicare prescribing footprint (2023)

The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.

  • Nervous system

    98.9%
    Other antiepileptics40.9%
    Levetiracetam26%Lacosamide18%Xcopri17%Briviact12%Topiramate11%Vimpat7%Keppra4%Topamax2%Epidiolex2%Levetiracetam Er1%Trokendi Xr1%
    Part D<11 patients
    Mood Stabilizer20.5%
    Lamotrigine59%Lamotrigine Er22%Carbamazepine Er6%Lamictal5%Tegretol Xr4%Carbamazepine2%Lamictal Xr2%
    Part D<11 patients

    + 15 more classes in this area

  • Metabolism & gastrointestinal

    0.7%
    Carnitine Analog0.7%
    Levocarnitine100%
    Part D<11 patients
  • Sensory organs

    0.4%
    Carbonic Anhydrase Inhibitor0.4%
    Acetazolamide100%
    Part D<11 patients
Where care is delivered (Part B)0% facility · 100% office

Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.

Publications

Matched to this physician's OpenAlex author record; most-cited works shown first.

Similar KOLs

Other experts from the same institution or the same specialty.

A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments, shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”